Innovative Drug Modalities for the Treatment of Advanced Prostate Cancer

被引:0
|
作者
Capuozzo, Maurizio [1 ]
Santorsola, Mariachiara [2 ]
Ianniello, Monica [3 ]
Ferrara, Francesco [1 ]
Zovi, Andrea [4 ]
Petrillo, Nadia [3 ]
Castiello, Rosa [3 ]
Fantuz, Maria Rosaria [3 ]
Ottaiano, Alessandro [2 ]
Savarese, Giovanni [3 ]
机构
[1] ASL Naples 3, Coordinamento Farmaceut, I-80056 Ercolano, Italy
[2] IRCCS G Pascale, Ist Nazl Tumori Napoli, Via M Semmola, I-80131 Naples, Italy
[3] Ctr Polidiagnost Strumentale Srl, AMES, Via Padre Carmine Fico 24, I-80013 Casalnuovo Di Napoli, Italy
[4] Minist Hlth, Viale Giorgio Ribotta 5, I-00144 Rome, Italy
关键词
prostate cancer; androgen-deprivation therapy; immunotherapy; PARP inhibitors; precision medicine; PHASE-III TRIAL; SIPULEUCEL-T; DOUBLE-BLIND; PLUS STANDARD; OPEN-LABEL; CASTRATION; IPILIMUMAB; IMMUNOTHERAPY; ENZALUTAMIDE; MULTICENTER;
D O I
10.3390/diseases12050087
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Prostate cancer, a prevalent malignancy affecting the prostate gland, is a significant global health concern. Androgen-deprivation therapy (ADT) has proven effective in controlling advanced disease, with over 50% of patients surviving at the 10-year mark. However, a diverse spectrum of responses exists, and resistance to ADT may emerge over time. This underscores the need to explore innovative treatment strategies for effectively managing prostate cancer progression. Ongoing research endeavors persist in unraveling the complexity of prostate cancer and fostering the development of biologic and innovative approaches, including immunotherapies and targeted therapies. This review aims to provide a valuable synthesis of the dynamic landscape of emerging drug modalities in this context. Interestingly, the complexities posed by prostate cancer not only present a formidable challenge but also serve as a model and an opportunity for translational research and innovative therapies in the field of oncology.
引用
收藏
页数:22
相关论文
共 50 条
  • [1] Innovative approaches to the hormonal treatment of advanced prostate cancer
    Trachtenberg, J
    EUROPEAN UROLOGY, 1997, 32 : 78 - 80
  • [2] Treatment modalities for localised prostate cancer
    Abu-Ghanem, Yasmin
    Madhavan, Subash Guru
    Kirby, Roger
    Challacombe, Ben
    TRENDS IN UROLOGY & MENS HEALTH, 2012, 3 (02) : 21 - 25
  • [3] Neoadjuvant and adjuvant treatment modalities for prostate cancer
    Erkan, Erkan
    Toktas, Gokhan
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2011, 10 (02): : 63 - 69
  • [4] Targeted nanomedicine modalities for prostate cancer treatment
    Cohen, Lital
    Livney, Yoav D.
    Assaraf, Yehuda G.
    DRUG RESISTANCE UPDATES, 2021, 56
  • [5] New treatment modalities in advanced thyroid cancer
    Kapiteijn, E.
    Schneider, T. C.
    Morreau, H.
    Gelderblom, H.
    Nortier, J. W. R.
    Smit, J. W. A.
    ANNALS OF ONCOLOGY, 2012, 23 (01) : 10 - 18
  • [6] Promising drug for advanced prostate cancer
    Benmaamar, Ramla
    LANCET ONCOLOGY, 2013, 14 (01): : E10 - E10
  • [7] NEW DRUG FOR ADVANCED PROSTATE CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2010, 110 (10) : 29 - 30
  • [8] A NEW DRUG FOR ADVANCED PROSTATE CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2009, 109 (04) : 30 - 31
  • [9] Treatment of Advanced Prostate Cancer
    Teo, Min Yuen
    Rathkopf, Dana E.
    Kantoff, Philip
    ANNUAL REVIEW OF MEDICINE, VOL 70, 2019, 70 : 479 - 499
  • [10] TREATMENT OF ADVANCED CANCER OF THE PROSTATE
    SAGASTER, P
    FLAMM, J
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 1988, 138 (08) : 169 - 173